Get the Stockscreener App
0.00
100.00%
-19.23
After Hours:
19.27
19.27
+
Direxion Daily Lly Bear 1 X Etf stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$19.23
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$27.16
Direxion Daily Lly Bear 1 X Etf Stock (ELIS) Company Profile
Name
Direxion Daily Lly Bear 1 X Etf
Sector
Industry
Phone
-
Address
-
Compare ELIS vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELIS
Direxion Daily Lly Bear 1 X Etf
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
379.73 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
770.19 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
773.92 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.01 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
718.96 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily Lly Bear 1 X Etf Stock (ELIS) Latest News
LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs - Barchart.com
Insider Moves Are Sending Mixed Signals Across the Tech Sector - Barchart.com
What You Need to Know Ahead of Eli Lilly's Earnings Release - Barchart.com
Eli Lilly Is Buying AtaiBeckley in $2.8 Billion Deal. What It Means for LLY Stock - Barchart.com
AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years - Barchart.com
le Roux vs Jamshidi | Prediction Markets - Coinbase
Los Angeles Knight Riders vs Washington Freedom: Team Total Runs - Coinbase
All Gamers vs. Team Heretics - Coinbase
3 Penny Stocks Under $5 Backed by Real Revenue Growth - Barchart.com
Stocks Push Higher as Chipmakers and AI Companies Rebound - Barchart.com
Moderna Stock: Is MRNA Outperforming the Health Care Sector? - Barchart.com
Even If Eli Lilly Stock Continues to Shine, Stay Away from This Pharmaceutical ETF - Barchart.com
5 Best Growth Stocks for the Next 10 Years - Barchart.com
Is Johnson & Johnson Stock Outperforming the Dow? - Barchart.com
The $4 Billion Reason Eli Lilly Stock Is Up Today - Barchart.com
3 Vanguard Dividend Funds for Low-Cost Income - Barchart.com
'No One Cares' – Over 20 Leveraged ETFs Shut Down In April, Including Crypto's LMBO And REKT - Stocktwits
Do Wall Street Analysts Like Eli Lilly Stock? - Barchart.com
Option Volatility And Earnings Report For May 48 - Barchart.com
Dear Veeva Systems Stock Fans, Mark Your Calendar for May 7 - Barchart.com
GLP-1 Sales Continue to Lift Eli Lilly. Does That Make LLY Stock a Buy? - Barchart.com
Should You Buy the Dip in Eli Lilly Stock Today? - Barchart.com
Amazon Aims to Take Over the GLP-1 Market Next. Will That Move the Needle for AMZN Stock? - Barchart.com
Volatility Meets Earnings Season – Q1 2026 - Direxion
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity (NYSEARCA:CURE) - Seeking Alpha
Stock List: Research Stocks from Around the World - GuruFocus
The Next Big AI Winner Might Not Be a Tech Company - Barchart.com
Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy? - barchart.com
Eli Lilly Pops on GLP-1 Pill Approval. Should You Buy LLY Stock Here? - Barchart.com
Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You Buy LLY Stock to Profit? - Barchart.com
Direxion Daily LLY Bear 1X Shares (NASDAQ:ELIS) Short Interest Up 52.0% in March - Defense World
Want Income and Growth? This Simple 3-ETF Portfolio Does Both - Barchart.com
Should You Chase the Rally in Hims & Hers Stock Today? - Barchart.com
Is Moderna Stock Outperforming the Dow? - Barchart.com
Is Bristol-Myers Squibb Stock Underperforming the Nasdaq? - Barchart.com
Is Eli Lilly Stock Underperforming the S&P 500? - Barchart.com
Stocks Sink on US Trade Uncertainty and Fresh AI Worries - Barchart.com
Direxion Announces Reverse Split of JDST, SOXS, DUST, HIBS, MUD & TSLS - Yahoo Finance
Eli Lilly Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
Novo Nordisk Is Getting a Major Boost from Amazon for Its New Wegovy Pill. Does That Make NVO Stock a Buy Here? - Barchart.com
Q4 Earnings: Beat, Miss, or Market Whiplash? - Direxion
ETF Market Trends: Updated News & Real-Time Quotes & In-Depth Data Analysis - TradingKey
As Eli Lilly Cuts Zepbound Prices, Should You Buy, Sell, or Hold LLY Stock? - Barchart.com
How Is Eli Lilly’s Stock Performance Compared to Other Pharmaceuticals? - Barchart.com
Are Wall Street Analysts Predicting Eli Lilly Stock Will Climb or Sink? - Barchart
Top ETFs with heavy exposure to Magnificent 7 stocks as big tech week lies ahead - Seeking Alpha
Q3 Earnings: Beat, Miss, or Mayhem. All Fuel for the Bold - Direxion
TBXU: Biotech Top 5 Bull 2X ETF - Direxion
Leverage Shares 2x Long AVGO Daily ETF (AVGG) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Leveraged ETFs: Single-Stock Surge - Seeking Alpha
Defiance Daily Target 2X Long CVNA ETF (CVNX) Short Interest & Short Float | Updated May 2026 - MarketBeat
Direxion Daily Lly Bear 1 X Etf Stock (ELIS) Financials Data
There is no financial data for Direxion Daily Lly Bear 1 X Etf (ELIS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.48%
0.13%
Cap:
|
Volume (24h):